malondialdehyde has been researched along with Parkinson Disease, Secondary in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 8 (88.89) | 24.3611 |
| 2020's | 1 (11.11) | 2.80 |
| Authors | Studies |
|---|---|
| Ahmed, A; El-Sayed, EK; Morsy, EE; Nofal, S | 1 |
| Azizi, Z; Farhadi, M; Manouchehrabadi, M; Torkaman-Boutorabi, A | 1 |
| Ba, YY; Guo, WW; Liu, HL; Wang, H; Wang, M; Wu, X; Yang, H; Zheng, L | 1 |
| Ding, F; Dong, X; Gao, X; Ji, J; Qin, J; Wu, M; Yu, S; Zhang, J; Zhang, Q; Zhang, Y; Zhou, L | 1 |
| Chen, F; Chen, HQ; He, C; Li, WZ; Wang, J; Wu, WY; Wu, YY; Yin, YY | 1 |
| Sutalangka, C; Wattanathorn, J | 1 |
| Guo, SQ; Hu, ZW; Li, WL; Zou, XD | 1 |
| Alipour Heidari, M; Dargahi, T; Faraji, A; Fraidouni, N; Haghdoost-Yazdi, H; Najafipour, R; Piri, H | 1 |
| Baluchnejadmojarad, T; Ghalami, J; Mansouri, M; Mokhtari, Z; Roghani, M | 1 |
9 other study(ies) available for malondialdehyde and Parkinson Disease, Secondary
| Article | Year |
|---|---|
Neuroprotective effect of agmatine (decarboxylated l-arginine) against oxidative stress and neuroinflammation in rotenone model of Parkinson's disease.
Topics: Agmatine; Animals; Cytokines; Disease Models, Animal; Glial Fibrillary Acidic Protein; Glutathione; Male; Malondialdehyde; Mesencephalon; Neuroprotective Agents; Oxidative Stress; Parkinson Disease, Secondary; Rats, Sprague-Dawley; Rotenone; Tyrosine 3-Monooxygenase | 2019 |
Carvacrol Protects Against 6-Hydroxydopamine-Induced Neurotoxicity in In Vivo and In Vitro Models of Parkinson's Disease.
Topics: Animals; Annexins; Behavior, Animal; Cell Survival; Corpus Striatum; Cymenes; Dose-Response Relationship, Drug; Glutathione; Lipid Peroxidation; Male; Malondialdehyde; Nerve Degeneration; Neuroprotective Agents; Oxidopamine; Parkinson Disease, Secondary; PC12 Cells; Rats; Reactive Oxygen Species | 2020 |
[Protective effect of alkaloids from Piper longum in rat dopaminergic neuron injury of 6-OHDA-induced Parkinson's disease].
Topics: Administration, Oral; Alkaloids; Animals; Apomorphine; Catalase; Dopamine Agonists; Dopaminergic Neurons; Glutathione; Glutathione Peroxidase; Male; Malondialdehyde; Motor Activity; Neostriatum; Nitric Oxide; Nitric Oxide Synthase; Oxidopamine; Parkinson Disease, Secondary; Piper; Random Allocation; Rats; Rats, Sprague-Dawley; Substantia Nigra; Superoxide Dismutase; Tyrosine 3-Monooxygenase | 2014 |
Pyrroloquinoline quinone-conferred neuroprotection in rotenone models of Parkinson's disease.
Topics: Animals; Antioxidants; Cell Line; Cell Survival; Gene Expression Regulation; Glutathione; Humans; Malondialdehyde; Neuroprotective Agents; Parkinson Disease, Secondary; PQQ Cofactor; Rats; Rotenone; Superoxide Dismutase; Tyrosine 3-Monooxygenase; Vesicular Monoamine Transport Proteins | 2015 |
Biochanin A protects dopaminergic neurons against lipopolysaccharide-induced damage and oxidative stress in a rat model of Parkinson's disease.
Topics: Animals; Behavior, Animal; Dopaminergic Neurons; Enzyme Activation; Genistein; Glutathione Peroxidase; Lipopolysaccharides; Macrophage Activation; Male; Malondialdehyde; Microglia; NADPH Oxidases; Neuroprotective Agents; Oxidative Stress; Parkinson Disease, Secondary; Rats; Rats, Sprague-Dawley; Superoxide Dismutase | 2015 |
Novel Food Supplement "CP1" Improves Motor Deficit, Cognitive Function, and Neurodegeneration in Animal Model of Parkinson's Disease.
Topics: Acetylcholinesterase; Animals; Behavior, Animal; Brain; Cholinergic Neurons; Cognition; Cyperus; Dietary Supplements; Disease Models, Animal; Dopaminergic Neurons; Functional Food; GPI-Linked Proteins; Male; Malondialdehyde; Monoamine Oxidase; Motor Activity; Nerve Degeneration; Oxidative Stress; Oxidopamine; Parkinson Disease, Secondary; Plant Extracts; Rats, Wistar; Spatial Memory; Time Factors; Tyrosine 3-Monooxygenase; Zingiber officinale | 2016 |
NAMPT protects against 6-hydroxydopamine-induced neurotoxicity in PC12 cells through modulating SIRT1 activity.
Topics: Acrylamides; Animals; Cell Survival; Cytokines; L-Lactate Dehydrogenase; Malondialdehyde; Nicotinamide Mononucleotide; Nicotinamide Phosphoribosyltransferase; Oxidopamine; Parkinson Disease, Secondary; PC12 Cells; Piperidines; Rats; Sirtuin 1 | 2016 |
Blockade of fast A-type and TEA-sensitive potassium channels provide an antiparkinsonian effect in a 6-OHDA animal model.
Topics: 4-Aminopyridine; Animals; Antiparkinson Agents; Apomorphine; Dose-Response Relationship, Drug; Drug Synergism; Male; Malondialdehyde; Medial Forebrain Bundle; Neuroprotective Agents; Oxidopamine; Parkinson Disease, Secondary; Potassium Channel Blockers; Rats; Rotarod Performance Test; Tetraethylammonium | 2017 |
Sesamin imparts neuroprotection against intrastriatal 6-hydroxydopamine toxicity by inhibition of astroglial activation, apoptosis, and oxidative stress.
Topics: Animals; Apoptosis; Astrocytes; Behavior, Animal; Caspase 3; Dioxoles; Gliosis; Lignans; Male; Malondialdehyde; Neostriatum; Neuroprotective Agents; Oxidative Stress; Oxidopamine; Parkinson Disease, Secondary; Postural Balance; Rats; Rats, Wistar; Reactive Oxygen Species; Superoxide Dismutase | 2017 |